Kiora Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-13.04	-13.58	-13.77	-6.86	-7.1	-10.81	-13.22	-13.34	-16.62	-1.77	Upgrade
Depreciation & Amortization	0.06	0.13	0.23	0.2	0.21	0.04	0.02	0.01	0	0	Upgrade
Share-Based Compensation	0.75	0.46	0.84	0.72	0.85	0.88	0.87	0.51	1.22	0.03	Upgrade
Other Operating Activities	2.14	2.56	2.03	-1.38	-2.12	-0.95	5.86	4.41	2.71	0.79	Upgrade
Operating Cash Flow	-9.56	-10.43	-10.68	-7.32	-8.15	-10.84	-6.47	-8.41	-4.46	-0.95	Upgrade
Capital Expenditures	0	0.01	-0.06	-0.02	0	-0.02	-0.04	0	0	0	Upgrade
Acquisitions	0	0	-0.09	-0.22	0	0	0	0.19	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-0.25	-	-0.01	-0.02	-	Upgrade
Investing Cash Flow	0	0.01	-0.16	-0.24	0	-0.27	-0.04	0.17	-0.02	0	Upgrade
Share Issuance / Repurchase	6.15	5.36	17.75	4.5	1.78	10.11	10.68	3.5	14.13	0.01	Upgrade
Debt Issued / Paid	0	0	-0.21	0.28	-0	-0.01	-0.01	-0	0	1.76	Upgrade
Other Financing Activities	-0.19	3.26	0.05	0.22	2.15	1.21	-	-	-1.51	-1.15	Upgrade
Financing Cash Flow	5.97	8.62	17.58	5	3.92	11.3	10.67	3.5	12.62	0.61	Upgrade
Exchange Rate Effect	0.04	-0.09	-0.08	-0.03	0.01	0.01	0	0.01	0.09	0	Upgrade
Net Cash Flow	-3.55	-1.89	6.67	-2.59	-4.23	0.2	4.17	-4.73	8.23	-0.33	Upgrade
Free Cash Flow	-9.56	-10.42	-10.74	-7.34	-8.15	-10.86	-6.51	-8.41	-4.46	-0.95	Upgrade
Free Cash Flow Margin	-	-	-	-60844.56%	-303.57%	-657.45%	-1596.38%	-1257.09%	-	-	Upgrade
Free Cash Flow Per Share	-1.97	-14.23	-44.54	-63.92	-102.53	-183.71	-273.72	-571.42	-434.05	-2957.23	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).